文献速递美容整形

术前使用神经调节剂优化上睑成形术与眉提升术的手术效果

Preoperative Use of Neuromodulators to Optimize Surgical Outcomes in Upper Blepharoplasty and Brow Lift.
PubMed 文献 · Aesthet Surg J · 2018-01-01

作者介绍其围手术期使用神经调节剂的综合方案:对存在额肌活动过度的上睑皮肤松弛患者,术前两周以15至20单位Botox Cosmetic治疗额肌,曾接受眉部降肌神经调节剂治疗者需等待四个月至产品消退。2002至2016年共治疗521例患者(458女、63男),该方法未导致上睑皮肤过度切除或兔眼,术前发现上睑下垂39例(31女、8男)、眉下垂131例(97女、34男)。

要点

  • 上睑成形术与眉提升术前评估应纳入眉位置与额肌活动过度。
  • 术前两周以15至20单位Botox Cosmetic治疗额肌。
  • 曾治疗眉部降肌者需等待四个月至产品消退再手术。

核心结论

  • 上睑成形术与眉提升术前评估应纳入眉位置与额肌活动过度。
  • 术前常规以神经调节剂治疗活动过度的额肌,并等待眉部降肌既往神经调节剂消退,可揭示真实解剖眉位置以优化手术规划。

研究设计与样本

  • 作者介绍其围手术期使用神经调节剂的综合方案。
  • 2002至2016年共治疗521例因眶周年轻化就诊的额肌活动过度患者,其中女性458例、男性63例。

主要发现

  • 该方法未导致上睑皮肤组织过度切除,也未导致兔眼。
  • 术前发现上睑下垂39例(女性31例、男性8例)。
  • 术前发现眉下垂131例(女性97例、男性34例)。

关键数值与推荐

  • 对存在上睑皮肤松弛伴额肌活动过度且要求上睑成形术的患者,采用神经调节剂治疗方案。
  • 曾接受眉部降肌神经调节剂治疗者,等待至末次治疗后四个月以允许产品消退。
  • 术前两周以15至20单位Botox Cosmetic治疗额肌。

临床怎么用

  • 作者提出上睑成形术与眉提升术前评估应考虑眉位置与额肌活动过度。
  • 作者提出术前常规以神经调节剂治疗活动过度的额肌,并等待眉部降肌既往神经调节剂消退,以揭示真实解剖眉位置并优化手术规划。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Upper eyelid dermatochalasis often triggers frontalis hyperactivity in an effort to elevate the upper lids away from the visual axis. Similarly, prior neuromodulator treatment of the brow depressors may cause false elevation of the brows, diminishing the extent of preoperative brow ptosis or dermatochalasis. Studies have quantified postoperative brow ptosis and recurrent dermatochalasis following upper blepharoplasty, but a methodology to predict the postoperative brow position remains to be elucidated. OBJECTIVES: The authors present our comprehensive perioperative protocol utilizing neuromodulators to optimize results of upper blepharoplasty and brow lift. METHODS: In patients presenting with upper lid dermatochalasis and frontalis hyperactivity, who request upper blepharoplasty, the authors apply a neuromodulator treatment protocol. Patients with prior neuromodulator treatment of brow depressors wait four months after the last treatment to allow for product attrition. Two weeks prior to surgery, the authors treat the frontalis with 15 to 20 units of Botox Cosmetic. RESULTS: From 2002 to 2016, the authors treated 521 patients (458 women, 63 men) with frontalis hyperactivity who presented for periorbital rejuvenation. This method has led to neither excessive resection of upper eyelid skin tissue nor lagophthalmos. Preoperatively, the authors have unveiled upper eyelid ptosis in 39 patients (31 women, 8 men) and brow ptosis in 131 patients (97 women, 34 men). CONCLUSIONS: Brow position and frontalis hyperactivity should be taken into consideration during preoperative evaluation for upper blepharoplasty and brow lift. Routine preoperative treatment of the hyperactive frontalis with neuromodulator, along with attrition of prior neuromodulator in the brow depressors, reveals the true anatomic brow position to optimize surgical planning.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Sweis IE, Hwang L, Cohen M, et al. Preoperative Use of Neuromodulators to Optimize Surgical Outcomes in Upper Blepharoplasty and Brow Lift. Aesthet Surg J. 2018. PMID: 29474688. doi:10.1093/asj/sjy049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。